Malassezia folliculitis is an under-recognizedentity commonly affecting the face and upper trunk. Clinical picture mimics acne vulgaris and diagnosis is challenging at times. 10% potassium hydroxide examination is usually performed to confirm the diagnosis. This study sought to describe the dermoscopic features in Malassezia folliculitis. Patients diagnosed clinically with Malassezia folliculitis and confirmed by 10% potassium hydroxide preparation were included in the study. Dermoscopy was performed with a videodermatoscope [Dinolite AM413ZT; Polarising] from the most representative lesion. A total of 45 patients (M:F = 1:0.8 ) were recruited. All patients had monomorphic papulo-pustular lesions. Itching was present in 64.4% patients. Dermoscopy reveled folliculocentricity (100%), perilesional background erythema (100%), dotted/linear/tortous vessels (88.9%), dirty white scaling (77.8%), hypo pigmentation of hair follicle (64.4%), coiled/looped hairs (57.8%) and broken hairs (13.3%). In conclusion, dermoscopy shows typical features in Malassezia folliculitis and can serve as a office based tool for identification of this entity.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ad.2020.05.022DOI Listing

Publication Analysis

Top Keywords

malassezia folliculitis
20
10% potassium
8
potassium hydroxide
8
features malassezia
8
malassezia
5
folliculitis
5
dermoscopy
4
dermoscopy auxiliary
4
auxiliary tool
4
tool assessment
4

Similar Publications

A niche in the context of microorganisms defines the specific ecological role or habitat inhabited by microbial species within an ecosystem. For the human commensal Malassezia, the skin surface is considered its primary niche, where it adapts to the skin environment by utilising lipids as its main carbon and energy source. However pathogenic characteristics of Malassezia include the production of allergens, immune modulation and excessive lipid utilisation, which result in several diseases such as pityriasis versicolor, seborrheic dermatitis, Malassezia folliculitis and atopic dermatitis.

View Article and Find Full Text PDF

folliculitis (MF) is a fungal infection that often presents with pruritic follicular papules and pustules, primarily affecting the upper body. Due to its clinical similarity to bacterial folliculitis, misdiagnosis and delayed treatment are common. In this report, we present the case of a 16-year-old male who developed persistent pruritic papules on his upper back and chest, initially misdiagnosed as bacterial folliculitis.

View Article and Find Full Text PDF
Article Synopsis
  • - Recent research on nonscarring scalp folliculitis (NSSF) indicates a potential link to Malassezia fungi rather than just bacterial infections, which has not been extensively studied before.
  • - A review of 26 NSSF patients revealed that 96% had Malassezia spores present, and antifungal treatment effectively reduced symptoms in 79% of cases.
  • - The study suggests that immunosuppression might increase vulnerability to NSSF, and while antifungal treatment is helpful, about 35% of patients experienced recurrence, highlighting the need for ongoing therapy.
View Article and Find Full Text PDF
Article Synopsis
  • The scalp microbiome consists of various microorganisms that help maintain scalp health and control inflammation, but dysregulation can lead to conditions like alopecia areata, dandruff, scalp psoriasis, and folliculitis.
  • Research shows different microbial populations are linked to specific scalp conditions, with certain bacteria and fungi being more prevalent in patients compared to healthy individuals.
  • Treatment options typically involve antifungals, but emerging alternatives, such as coconut oils and shampoos with probiotics, may help restore a healthy scalp microbiome and improve symptoms.
View Article and Find Full Text PDF
Article Synopsis
  • Recent research indicates that cold atmospheric plasma (CAP) could effectively inhibit the growth of Malassezia yeasts, suggesting it might be a new treatment for Malassezia folliculitis (MF).
  • The study aimed to evaluate the antifungal effectiveness and patient tolerability of CAP compared to the traditional treatment itraconazole in a controlled trial involving 50 patients with MF.
  • Results showed that while CAP inhibited yeast growth in lab tests, it had a success rate of 40% in patients, compared to 58.3% for itraconazole, with no significant differences observed in quality of life or safety profiles between the two treatments.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!